期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Effectiveness of Moxibustion for Exercise-Induced Fatigue——A Systematic Review for Randomized Controlled Trials 被引量:2
1
作者 钟大可 唐丹 +2 位作者 薛力 文进 李幼平 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2016年第2期130-140,共11页
Objective:To review and assess the effect of single moxibustion for exercise-induced fatigue(EIF).Methods:Computer-search for 8 medical databases and 5 clinical trail registries were conducted for randomized contr... Objective:To review and assess the effect of single moxibustion for exercise-induced fatigue(EIF).Methods:Computer-search for 8 medical databases and 5 clinical trail registries were conducted for randomized controlled trials(RCTs),added with hand-search for 10 Chinese acupuncture-moxibustion journals and additional references.Data from included RCTs were pooled by RevMan5.1.Methodology quality of RCTs was judged by Cochrane Collaboration assessment tool while quality of primary outcomes was evaluated by GRADE3.2.Results:Five RCTs were finally included,all reported in small sample size with high risk of bias.Comparisons on single moxibustion and rest relief(without treatment) were studied.Six outcomes were reported,all favored moxibustion to rest relief for EIF.Primary outcomes showed as rating of perceived exertion(RPE) with mean difference(MD)=-0.49,95%confidence interval(CI)[-0.80,-0.19],800-m race performance with MD=^-2.21,95%CI[-3.57,-0.85],and Harvard Step Index(HSI) with MD=14.75,95%CI[8.35,21.15].Moreover,all primary outcomes as RPE,800-m race performance and HSI were rated low quality.Conclusions:Single moxibustion might be considered effective for EIF.However,due to small samples of included RCTs,high risk of bias among studies and poor quality of primary outcomes and subjects restricted to Chinese athletes only,these results present limitation,and should be taken with caution for practice.More large-size studies with rigorous design are warranted to further test effectiveness of moxibustion for EIF. 展开更多
关键词 moxibustion exercise-induced fatigue randomized controlled trial systematic review
原文传递
The intervention effect of virtual reality technology on patients recovering from traumatic brain injury: a meta analysis 被引量:1
2
作者 Xiao-Xiao Yang Yuan-Yuan Chen Fan-Jie Meng 《TMR Integrative Medicine》 2019年第24期1-9,共9页
Objective:To systematically evaluate the intervention effect of virtual reality technology on patients recovering from traumatic brain injury.Methods:The computer retrieved CNKI,VIP,Wan Fang,Embase,The Cochrane Librar... Objective:To systematically evaluate the intervention effect of virtual reality technology on patients recovering from traumatic brain injury.Methods:The computer retrieved CNKI,VIP,Wan Fang,Embase,The Cochrane Library and PubMed database,and collected randomized controlled trials of virtual reality technology combined with routine rehabilitation training and simple routine rehabilitation training on patients recovering from traumatic brain injury.The retrieval period was from the establishment of the database to July 2019.Two researchers independently screened the literature,extracted the data and evaluated the risk of bias in the included studies.RevMan 5.3 software was used for analysis.Results:A total of 7 articles were included.Meta-analysis results showed that virtual reality technology could significantly improve balance function(mean difference(MD)=3.72,95%confidence interval(CI)(2.61,4.83),P<0.001),daily living ability(MD=11.87,95%CI(10.42,13.32),P<0.001),and exercise ability(MD=3.83,95%CI(2.30,5.36),P<0.001).In the aspect of posture control ability,the trajectory motion length,trajectory velocity and peripheral area were improved(standardised mean difference(SMD)=0.80,95%CI(1.19,0.41),P<0.0001),(SMD=0.95,95%CI(1.45,0.45),P=0.0002),(SMD=0.69,95%CI(1.11,0.26),P=0.001).Conclusion:Virtual reality technology can significantly improve the balance function,daily living ability,motor function and postural control ability of patients recovering from cerebral trauma.Limited by the quantity and quality of the included studies,the above conclusions need to be verified by more high-quality studies. 展开更多
关键词 Virtual reality Traumatic brain injury Balance systematic review Randomized controlled trial
下载PDF
Sodium Tanshinone Ⅱ A Sulfonate Injection as Adjuvant Treatment for Unstable Angina Pectoris: A Meta-Analysis of 17 Randomized Controlled Trials 被引量:19
3
作者 TAN Di WU Jia-rui +2 位作者 ZHANG Xiao-meng LIU Shi ZHANG Bing 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2018年第2期156-160,共5页
Objective: To systematically evaluate the effectiveness and safety of Sodium Tanshinone ⅡA Sulfonate Injection(STS) as one adjuvant therapy for treating unstable angina pectoris(UAP). Methods: Randomized contro... Objective: To systematically evaluate the effectiveness and safety of Sodium Tanshinone ⅡA Sulfonate Injection(STS) as one adjuvant therapy for treating unstable angina pectoris(UAP). Methods: Randomized controlled trials(RCTs) of UAP treated by STS were searched in the China National Knowledge Infrastructure Database(CNKI), VIP Database for Chinese Technical Periodicals(VIP), Wanfang Database, the Chinese Biomedical Literature Database(CBM), Web of Science, the Cochrane Library, Embase, and Pub Med, which from inception to January, 2016. The Cochrane Risk Assessment Tool was used to evaluate the methodological quality of the RCTs. The Review Manager 5.3 software was used to conduct the metaanalysis. Results: The results showed that 17 RCTs involving 1,372 patients were included. The meta-analysis indicated that the combined use of STS and Western medicine(WM) in the treatment of UAP can obviously improve the total effective rate [risk ratio(RR)=1.31, 95% confidence interval(CI)(1.24,1.39), P〈0.0001], and the total effective rate of electrocardiogram [RR=1.43, 95% CI(1.30,1.56), P〈0.0001], decrease the level of CRP [mean difference(MD)=–3.06, 95%CI(–3.85, –2.27), P〈0.00001], fibrinogen [MD=–1.03, 95% CI(–1.16, –0.89), P〈0.00001], and whole blood high shear viscosity [MD=–0.70, 95% CI(–0.92, –0.49), P〈0.00001]. Additionally, the occurrence of adverse drug reaction of the experimental group was significantly higher than that of the control group [RR=3.57, 95% CI(1.28, 9.94), P〈0.05]. Conclusions: Compared with WM, the combined use of STS was more effective. 展开更多
关键词 Sodium Tanshinone A Sulfonate Injection Chinese medicine unstable angina pectoris randomized controlled trials systematic review meta-analysis
原文传递
Traditional Chinese Medicine for Diminished Ovarian Reserve: A Systematic Review and Meta-analysis 被引量:3
4
作者 Tian Xia Rui-hong Ma +4 位作者 Wei Mu Meng-di Hu Sai-hua Ma Shu-wen Mao Yu Fu 《Chinese Herbal Medicines》 CAS 2014年第2期93-102,共10页
Objective To assess the effectiveness and safety of traditional Chinese medicine(TCM)for women with diminished ovarian reserve(DOR).Methods A literature search was conducted in eight electronic databases for rando... Objective To assess the effectiveness and safety of traditional Chinese medicine(TCM)for women with diminished ovarian reserve(DOR).Methods A literature search was conducted in eight electronic databases for randomized controlled trials.Results Seventeen randomized controlled trials involving 1174 patients were included.Meta-analysis indicated that TCM was superior to Western medicine(WM)in reducing basal serum FSH level[MD=-1.70,95%CI(-2.63,-0.77);P=0.0004]and FSH/LH(MD=-0.43,95%CI[-0.56,-0.30];P=0.0001),and the effect was more obvious two months after the last treatment(MD=-4.60,95%CI[-6.26,-2.90],P〈0.000 01 and MD=-0.56,95%CI[-0.85,-0.28],P=0.0001),and increasing antral follicle count(AFC)(MD=0.44,95%CI[0.04-0.83];P=0.03).The review also revealed the positive role of CMM as an adjuvant to IVF-ET in improving pregnancy rate(PR=1.75,95%CI[1.25,2.46];P=0.001).Conclusion TCM,with its unique way of replenishing the kidney,may provide an effective and safe alternative therapy to patients with DOR. 展开更多
关键词 meta-analysis ovarian disease randomized controlled trial systematic review traditional Chinese medicine
原文传递
Toward Evidence-Based Chinese Medicine:Status Quo,Opportunities and Challenges 被引量:7
5
作者 CHEN Yao-long ZHAO Chen +11 位作者 ZHANG Li LI Bo WU Chuan-hong MU Wei WANG Jia-ying YANG Ke-hu LI You-ping CHEN Chiehfeng WANG Yong-yan WANG Chen BIAN Zhao-xiang SHANG Hong-cai 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2018年第3期163-170,共8页
How to test the treatments of Chinese medicine(CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and research... How to test the treatments of Chinese medicine(CM) and make them more widely accepted by practitioners of Western medicine and the international healthcare community is a major concern for practitioners and researchers of CM.For centuries,various approaches have been used to identify and measure the efficacy and safety of CM.However,the high-quality evidence related to CM that produced in China is still rare.Over the recent years,evidence-based medicine(EBM) has been increasingly applied to CM,strengthening its theoretical basis.This paper reviews the past and present state of CM,analyzes the status quo,challenges and opportunities of basic research,clinical trials,systematic reviews,clinical practice guidelines and clinical pathways and evidence-based education developed or conducted in China,pointing out how EBM can help to make CM more widely used and recognized worldwide. 展开更多
关键词 evidence-based medicine Chinese medicine randomized controlled trial systematic review clinical practice guidelines
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部